Featured Research

from universities, journals, and other organizations

Formaldehyde Exposure Associated With Risk Of Blood And Lymph System Malignancies

Date:
May 14, 2009
Source:
Journal of the National Cancer Institute
Summary:
Individuals exposed to relatively higher amounts of formaldehyde had a higher rate of death due to blood and lymph system malignancies than those exposed to lower levels of formaldehyde in a large cohort study.

Individuals exposed to relatively higher amounts of formaldehyde had a higher rate of death due to blood and lymph system malignancies than those exposed to lower levels of formaldehyde in a large cohort study.

In the National Cancer Institute's formaldehyde cohort, which was previously followed through 1994, formaldehyde exposure was associated with an increased risk of leukemia. In the current study, Laura Beane Freeman, Ph.D., of the NCI in Rockville, Md., and colleagues, extended the follow-up through 2004. The cohort includes 25,619 individuals exposed to formaldehyde at work.

With a median follow-up of 42 years, the investigators observed a positive association between all lymphohematopoietic malignancies and peak formaldehyde exposure, with a 1.37-fold higher risk among those with the highest peak exposures compared with those with the lowest level of peak exposures. There was no statistically significant association with cumulative exposure or average intensity of exposure. An excess risk was seen for several sub-types of these malignancies, most notably myeloid leukemia, with a 1.78-fold higher risk. Myeloid leukemia is the type most often associated with chemical exposures. The level of increased risk was highest earlier in the follow-up period and then declined steadily over time such that the cumulative excess risk no longer reached statistical significance.

"In the current follow-up, the overall risk of myeloid leukemia has declined from our previous report, but remains somewhat elevated. While that time trend may suggest that the previous excess risk estimates were due to chance, the pattern is consistent with a possible causal association, with the largest risks occurring closer in time to relevant exposure," the authors write. "It is our opinion that the overall pattern of risks seen in this extended follow-up of formaldehyde workers, while not definitive, warrants continued concern."

This research was published in the Journal of the National Cancer Institute May 12, 2009.


Story Source:

The above story is based on materials provided by Journal of the National Cancer Institute. Note: Materials may be edited for content and length.


Cite This Page:

Journal of the National Cancer Institute. "Formaldehyde Exposure Associated With Risk Of Blood And Lymph System Malignancies." ScienceDaily. ScienceDaily, 14 May 2009. <www.sciencedaily.com/releases/2009/05/090512192912.htm>.
Journal of the National Cancer Institute. (2009, May 14). Formaldehyde Exposure Associated With Risk Of Blood And Lymph System Malignancies. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2009/05/090512192912.htm
Journal of the National Cancer Institute. "Formaldehyde Exposure Associated With Risk Of Blood And Lymph System Malignancies." ScienceDaily. www.sciencedaily.com/releases/2009/05/090512192912.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins